Rapid Micro Biosystems (RPID) Appoints Dafni Bika to its Board
Get Alerts RPID Hot Sheet
Join SI Premium – FREE
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Dr. Dafni Bika to the Company’s Board of Directors (the “Board”).
“We are extremely pleased to welcome Dr. Bika to our Board of Directors,” said Robert Spignesi, President and Chief Executive Officer. “Dafni has more than 25 years of leadership experience in pharmaceutical development and manufacturing science and technology. She brings a wealth of knowledge and strategic insight that will contribute to our growth as we continue to establish the Growth Direct platform as the industry standard for automating pharmaceutical QC testing. We are excited to add her expertise to our Board.”
Dr. Bika currently serves as Senior Vice President and Global Head of Pharmaceutical Technology and Development at AstraZeneca plc, where she leads a global team of scientists and engineers in advancing synthetic molecules into approved medicines. Prior to joining AstraZeneca, Dr. Bika held senior executive roles at Bristol-Myers Squibb Company, overseeing Manufacturing Technology, Packaging Technology and Device Operations as well as Global Drug Product Manufacturing Science and Technology. Earlier in her career, she served as the Director of Global Pharmaceutical Commercialization at Merck & Co., Inc.
“I am honored to join the Board at Rapid Micro Biosystems,” said Dr. Bika. “I look forward to collaborating with the management team and my fellow Board members as we advance the Company’s mission to modernize pharmaceutical quality control and manufacturing with the Growth Direct platform.”
Dr. Bika holds a Ph.D. in Materials Science and Engineering from the University of Pennsylvania, a Master of Science in Materials Science and Engineering from the University of Rochester, NY, and a Diploma in Chemical Engineering from the National Technical University of Athens (Greece).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Mosaic sets pricing for tender offers on up to $1.4B in debt
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
Twitter, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share